0.087 USD
-0.03 (-27.8%)
0.083 USD
0 (-4.6%)
ChartMill assigns a Buy % Consensus number of 43% to PLXP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.22. This target is 12796.55% above the current price.
PLXP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PLXP.
In the previous month the buy percentage consensus was at a similar level.
PLXP was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-15 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-08-15 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-05-16 | Raymond James | Maintains | Outperform |
| 2021-12-07 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2021-09-21 | BWS Financial | Initiate | Buy |
| 2021-04-09 | Oppenheimer | Initiate | Outperform |
PLX PHARMA INC / PLXP FAQ
What do analysts expect the price target to be for PLX PHARMA INC (PLXP)?
6 analysts have analysed PLXP and the average price target is 11.22 USD. This implies a price increase of 12796.55% is expected in the next year compared to the current price of 0.087.
What is the consensus rating for PLXP stock?
The consensus rating for PLX PHARMA INC (PLXP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for PLX PHARMA INC stock?
The number of analysts covering PLX PHARMA INC (PLXP) is 6.